National Comprehensive Cancer Network

Video Modules

Employers: Paying for Drugs and Biologics in Cancer Care

Taped March 9, 2011 in Hollywood, Florida

This module focuses on employers' perspectives and includes the following topics:
  • At what level do large employers or coalitions of small to mid size employers get involved in tracking the use and expense of drugs and biologics under the medical benefits and under the pharmacy benefits
  • To what extent have expensive drugs and biologics for cancer care hit the radar screen of employers, large and small
  • In RFPs for insurers as vendors of health insurance benefits for employees, to what extent do employers outline their requirements for the benefit design, for the availability of case management, in disease management, specialty pharmacy, precertification, etc.
  • How do large employers track the performance of payors/insurers with specificity of approvals or denials for treatments prescribed by experts for cancer; are employees as patients receiving the benefits that they deserve
  • How specific do employers get in terms of discussing coverage policies regarding drugs and biologics with payors
  • What is the large employer preference for management of their drug benefits plans; insurers or PBMs and why


  • William  T.  McGivney, PhD, National Comprehensive Cancer Network (NCCN) (Moderator)
  • Daniel  Dragalin, MD, MPH, McKesson Health Services
  • Kirby  J.  Eng, RPh, CVS Caremark
  • Lynn  Zonakis, BA, BSN, Delta Air Lines

+ View Faculty Information

To learn more about NCCN Academy Video Modules or to take advantage of discounted Corporate Council rates for licensing of the NCCN Academy Video Modules, please contact Jennifer Tredwell

File Size: 133 MB       Length: 73 minutes       Last Updated: 07/20/2011

1-year subscription $5,000.00